DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer

This study was designed to develop and evaluate the effectiveness of a web-based supportive care program for individuals diagnosed with colorectal cancer undergoing cancer treatment. The program's effectiveness is evaluated based on the symptom burden and quality of life experienced by patients during cancer treatment. This randomized controlled trial was conducted with the participation of patients diagnosed with colorectal cancer receiving treatment at the Outpatient Chemotherapy Unit of Koç University Hospital. Participants were divided into two groups: an intervention group and a control group. Patients in the intervention group were provided with access to the web-based 'Sağlıkta Buluşalım (Meet in Health) Supportive Care Program' for 3 months in addition to routine care, while the control group received standard care. Data collection tools included a Descriptive Information Form, Edmonton Symptom Assessment System (ESAS), Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Website Usability Scale, and a Telephone Follow-up Form. Statistical analyses, including Mann-Whitney U, Pearson Chi-Square, Fisher's Exact, and Friedman tests, were planned to compare symptom levels and quality of life scores within and between groups over time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colonic Neoplasms Colorectal (Colon or Rectal) Cancer Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Koç University Hospital

Istanbul, 34840, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of colon cancer and receiving cancer treatment (within the first 3 months of diagnosis)
Being 18 years of age or older
Being able to read, understand, and communicate in Turkish
Having internet access
Being able to use a smartphone or computer
Having access to a smartphone or computer
Voluntary participation in the study

Exclusion criteria

Having a psychiatric illness
Having a disability that impairs cognitive functions
Refusing to participate in the study
Poor general health
Incompatibility between treatment appointments and the study's data collection schedule

Treatment and study plan

web based supportive care programme

Other

This study developed a supportive care program for individuals diagnosed with colorectal cancer who are undergoing cancer treatment, focusing on the symptoms and quality of life experienced by patients during treatment.

The sub-headings and content of the planned program were prepared within the framework of the "Supportive Care Framework," frequently used for cancer patients. This framework, comprising 7 main concepts (physical, emotional, social, psychosocial, spiritual/mental, informational, and practical-daily life changes), aims to provide a holistic approach to patients' needs.

Furthermore, the program content includes the experiences of individuals who have gone through similar experiences and have recovered from cancer. All these approaches constitute the unique values of this study.

Primary outcomes

Quality of Life Measured by the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) Scale

Time frame: From enrollment to the end of treatment at 3 months

The Functional Assessment in Cancer Treatment-Colorectal Cancer Scale (FACT-C) was administered to evaluate the quality of life of patients undergoing chemotherapy. The scale is part of the Functional Assessment in Chronic Disease Treatment (FACIT) measurement system and is used to assess common conditions seen in all cancer patients, as well as specific concerns associated with colorectal cancer.
Symptom Severity Measured by the Edmonton Symptom Assessment Scale

Time frame: From enrollment to the end of treatment at 3 months

The Edmonton Symptom Assessment Scale was used to evaluate the symptoms experienced by patients during chemotherapy treatment. The scale assesses 10 symptoms: pain, fatigue, nausea, sadness, anxiety, insomnia, loss of appetite, general malaise, shortness of breath, and other problems.

Sponsors and collaborators

Lead sponsor

Ilknur Yazicioglu

Other

Registry information

Official study title

Development And Evaluation of The Effectiveness of A Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Apr 6, 2026
Registry last updated: Apr 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting